Some aspects of the drug therapy of type 2 diabetes mellitus in overweight patients
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 5
Abstract
This is a mini-review of recent publications on hypoglycemic drugs applicable to the treatment of type 2 diabetes mellitus in overweight patients. The article discusses the following topics: the influence of medications on body weight, function of pancreatic beta-cells, indications for the intensive glycemic control and medication costs. Glucagon-like peptide-1 receptor agonists stimulate insulin secretion, slow down gastric emptying, cause satiety and reduce food intake, contributing to the weight loss. The sodium glucose cotransporter 2 inhibitors suppress the renal glucose reabsorption, lower blood pressure and contribute to a reduction of body weight. A body weight reduction should be awaited also from inhibitors of intestinal alpha-glucosidase. Hypoglycemic effects of the two latter drug classes are unrelated to the stimulation of insulin secretion by beta cells. It is known that the secretory function of pancreatic islets can be exhausted by a prolonged stimulation. In conclusion, the goals of glycemic control need to be individualized based on the age, prognosis, presence of cardiovascular disease, and risk of hypoglycemia. Appropriate management of hypertension, dyslipidemia, and other cardiovascular risk factors are of importance for the prevention of complications in type 2 diabetes mellitus.
Authors and Affiliations
S. V. Jargin
Keywords
Related Articles
- EP ID EP660877
- DOI 10.22141/2224-0721.15.5.2019.180046
- Views 51
- Downloads 0
Endocrinology: Review of Medical Periodicals of Ukraine and Russian Federation
.
Beware of Pesudohealers of Diabetes!
The article deals with pseudohealing, topical question of all medical specialities including endocrinology. Each physician knows negative consequences of pseudohealer’s actions for patients, however there are no particul...
Using the principle of multiparametric ultrasound for the diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
Background. The purpose of this study is evaluation of using the principle of multiparametric ultrasound (mp-US) for the diagnosis of nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2...
Predicting the Risk of Preeclampsia in Pregnant Women with Type 1 Diabetes Mellitus and Concomitant Diabetic Nephropathy: the Role of Genetic Markers
Introduction. Systematic reviews found that in diabetic nephropathy, there is a 2-fold risk of adverse effects for the fetus, and 5-fold — for the mother. Most complications in patients with diabetic nephropathy are medi...
Assessment of cardiovascular risk in patients with primary chronic gout combined with metabolic syndrome
Background. The purpose of the study is to ivestigate the frequency of metabolic syndrome (MS) and to assess the total cardiovascular risk in patients with primary chronic gout, depending on the presence of MS. Materials...